Updated Patent Situation on Key Products for Hepatitis C Treatment in Asia – August 2015

Updated Patent Situation on Key Products for Hepatitis C Treatment in Asia – August 2015

A summarized information of patents on sofosbuvir, ledipasvir and daclatasvir in parts of South and south-east Asia. The documents also covers situation of registration of these medications in the countries as on August 2015..read full document

/ News

Share the Post